Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment.

PURPOSE Although uncommon, melanoma is associated with poor survival characteristics among African Americans and Hispanics compared with non-Hispanic whites (NHWs). Low socioeconomic status (SES) is also associated with poor survival among patients with melanoma, but it is not known whether this is because of SES itself or because of treatment disparities. We set out to determine this by using the large, population-based California Cancer Registry (CCR) database as a model. PATIENTS AND METHODS We conducted a case-only analysis of CCR data (1993 to 2003), including a descriptive analysis of relevant clinical variables and SES. The SES variable used has been derived from principle component analysis of census block-level CCR data that was linked to census data to address seven indicators of SES. Univariate analyses of overall survival (OS) were conducted using the Kaplan-Meier method. Multivariate survival analyses were performed using Cox proportional hazard ratios (HRs). RESULTS A total of 39,049 incident patient cases of cutaneous melanoma, including 36,694 in NHWs; 127 in African Americans; 1,996 in Hispanics; and 262 in Asian-Americans, were analyzed. Higher SES was associated with an early stage at presentation (P < .0001), with treatment with surgery (P = .0005), and with prolonged survival (P < .0001). After adjustments for age, sex, histology, American Joint Committee on Cancer stage, anatomic site, treatment, and SES, a statistically significant increased risk of death was observed for African Americans compared with NHWs (HR, 1.60; 95% CI, 1.17 to 2.18); no survival differences were noted for Asians or Hispanics compared with NHWs in the adjusted analysis. CONCLUSION Low SES independently predicts poor outcome among patients with cutaneous melanoma. However, the poor OS observed for African American patients with melanoma is not explained by differences in treatment or SES.

[1]  J. Zell,et al.  Race, Socioeconomic Status, Treatment, and Survival Time among Pancreatic Cancer Cases in California , 2007, Cancer Epidemiology Biomarkers & Prevention.

[2]  D. Ansell,et al.  The black:white disparity in breast cancer mortality: the example of Chicago , 2007, Cancer Causes & Control.

[3]  Xiaocheng Wu,et al.  Annual report to the nation on the status of cancer, 1975–2003, featuring cancer among U.S. Hispanic/Latino populations , 2006, Cancer.

[4]  Xianglin L. Du,et al.  Ethnic differences among patients with cutaneous melanoma. , 2006, Archives of internal medicine.

[5]  D. Pinkel,et al.  Somatic activation of KIT in distinct subtypes of melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Sharan Campleman,et al.  Colorectal cancer stage at diagnosis by socioeconomic and urban/rural status in California, 1988–2000 , 2006, Cancer.

[7]  D. Pinkel,et al.  MC1R germline variants confer risk for BRAF-mutant melanoma. , 2006, Science.

[8]  J. Fridlyand,et al.  Distinct sets of genetic alterations in melanoma. , 2005, The New England journal of medicine.

[9]  D. Guerry,et al.  A population-based validation of the American Joint Committee on Cancer melanoma staging system. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  D. Henson,et al.  Cutaneous, ocular and visceral melanoma in African Americans and Caucasians , 2005, Melanoma research.

[11]  M. Weinstock,et al.  Association of UV index, latitude, and melanoma incidence in nonwhite populations--US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001. , 2005, Archives of dermatology.

[12]  R. Kirsner,et al.  Advanced presentation of melanoma in African Americans: the Miami-Dade County experience. , 2004, Journal of the American Academy of Dermatology.

[13]  Fangchao Ma,et al.  UV radiation, latitude, and melanoma in US Hispanics and blacks. , 2004, Archives of dermatology.

[14]  A. Halpern,et al.  Diet and melanoma in a case-control study. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[15]  B Rachet,et al.  Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001 , 2004, British Journal of Cancer.

[16]  C. Luke,et al.  A critical analysis of reasons for improved survival from invasive cutaneous melanoma , 2003, Cancer Causes & Control.

[17]  K. Hemminki,et al.  Level of education and the risk of cancer in Sweden. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  D. Hudson,et al.  Malignant melanoma in South Africans of mixed ancestry: a retrospective analysis , 2003, Melanoma research.

[19]  K. Czene,et al.  Socioeconomic factors in cancer in Sweden , 2003, International journal of cancer.

[20]  R. Cress,et al.  Patterns of chemotherapy use for women with ovarian cancer: a population-based study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[22]  W. Wright,et al.  Socioeconomic status and breast cancer incidence in California for different race/ethnic groups , 2001, Cancer Causes & Control.

[23]  C. Bellows,et al.  Melanoma in African‐Americans: Trends in biological behavior and clinical characteristics over two decades , 2001, Journal of surgical oncology.

[24]  Martin F. Mihm,et al.  Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  N Cascinelli,et al.  Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  P. Farmer,et al.  Redox regulation in human melanocytes and melanoma. , 2001, Pigment cell research.

[27]  J. Krischer,et al.  Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. , 2000, Journal of the American Academy of Dermatology.

[28]  W. Wright,et al.  Sociodemographic factors associated with prostatectomy utilization and concordance with the physician data query for prostate cancer (United States) , 1999, Cancer Causes & Control.

[29]  J Z Ayanian,et al.  Effects of health insurance and race on early detection of cancer. , 1999, Journal of the National Cancer Institute.

[30]  S. Gruber,et al.  Is physician detection associated with thinner melanomas? , 1999, JAMA.

[31]  G. Giles,et al.  A case-control study of melanomas of the soles and palms (Australia and Scotland) , 1999, Cancer Causes & Control.

[32]  L. Karnell,et al.  The National Cancer Data Base report on cutaneous and noncutaneous melanoma , 1998, Cancer.

[33]  E. Holly,et al.  Incidence of cutaneous melanoma among non-Hispanic Whites, Hispanics, Asians, and Blacks: an analysis of California Cancer Registry data, 1988-93 , 1997, Cancer Causes & Control.

[34]  S. London,et al.  Proportional melanoma incidence and occupation among White males in Los Angeles County (California, United States) , 1995, Cancer Causes & Control.

[35]  R. Dodge,et al.  Malignant melanoma in black Americans. A trend toward improved survival. , 1991, Archives of surgery.

[36]  C. Muir,et al.  International Classification of Diseases for Oncology , 1990 .

[37]  M. Weinstock,et al.  Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. , 1987, JAMA.

[38]  G. Currie,et al.  International Classification of Diseases for Oncology , 1977 .

[39]  Rafael Calvo,et al.  The National. , 1892 .

[40]  P. G. Lang,et al.  Association of UV Index, Latitude, and Melanoma Incidence in Nonwhite Populations—US Surveillance, Epidemiology, and End Results (SEER) Program, 1992 to 2001 , 2006 .

[41]  G. Peck,et al.  Advanced presentation of melanoma in African Americans. , 2004, Journal of the American Academy of Dermatology.

[42]  C. Cordon-Cardo,et al.  Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. , 1989, Oncogene.